Vetr Inc. upgraded McKesson Corporation (NYSE:MCK) to Strong-Buy in a report released today.
- Updated: September 16, 2016
Vetr Inc. has upgraded McKesson Corporation(NYSE:MCK) to Strong-Buy in a report released on 9/16/2016.
On 8/11/2016, Mizuho Securities reported on McKesson Corporation(NYSE:MCK) raised the target price from $174.00 to $197.00 that indicated a possible upside of 0.01%.
Showing a price of $168.97, McKesson Corporation (NYSE:MCK) traded 1.44% lower on the day. With the last stock price down 6.67% from the two hundred day average, compared to the S&P 500 Index which has decreased -0.01% over the same time. MCK has recorded a 50-day moving average of $188.37 and 200-day moving average of $178.44. Volume of trade was was down over the average, with 500,883 shares of MCK changing hands under the typical 1,390,240 shares.
See Graphic Below:
With a total market value of $0.0, McKesson Corporation has a price-earnings of 17 with a one-year low of $148.29 and a one-year high of $208.03.
A total of 15 equity analysts have reported on MCK. Four analysts rate the company a strong buy, seven firms rate the stock a buy, seven firms rate the company a hold, 0 rate the company to underperform, and finally 0 analystsrate the company as sell with a one year target stock price of $195.93
More About McKesson Corporation (NYSE:MCK)
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, and which is a payment technology.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.